Intra-abdominal Streptococcus agalactiae infection associated with myelofibrosis treated with ruxolitinib: a case report of an atypical clinical presentation-Reference-Cited by-同舟云学术

Intra-abdominal Streptococcus agalactiae infection associated with myelofibrosis treated with ruxolitinib: a case report of an atypical clinical presentation

Published:2022-01-08 Issue: Volume: Page:1-4
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Chen Jia¹²,Pan Lijuan¹²,Qu Shiqiang¹²,Qin Tiejun¹²,Xiao Zhijian¹²,Xu Zefeng¹²

Affiliation:

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

2. MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Funder

National Natural Science Funds

Tianjin Natural Science Funds

Chinese Academy of Medical Sciences Initiative Fund for Medical Sciences

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.2022420

Reference21 articles.

1. Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management

2. Managing side effects of JAK inhibitors for myelofibrosis in clinical practice

3. Streptococcus agalactiae infections and clinical relevance in adults, Thailand

4. Human placenta has no microbiome but can contain potential pathogens

5. Streptococcus agalactiae Native Valve Endocarditis: Uncommon Presentation of Multiple Myeloma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib;Reactions Weekly;2022-05